TABLE 3.
Compound | Fluconazole resistance |
||
---|---|---|---|
Strain SC5314 | Strain tacΔ/Δ | Strain upc2Δ/Δ | |
DMSO | 1× | 1× | 1× |
Aripiprazole (5 μM) | 32× | 1× | >4× |
Etofenamate (5 μM) | >256× | >128× | 1× |
Mometasone (5 μM) | 16× | 1× | >4× |
Penbutolol (5 μM) | 32× | 4× | >2× |
Pinaverium (5 μM) | 32× | 1/2× | >4× |
Prenylamine (5 μM) | 16× | 1× | >2× |
Thiethylperazine (5 μM) | 8× | 1× | >2× |
Fluconazole susceptibility assays were performed using a modified version of the CLSI broth microdilution method for the indicated strains in the presence and absence of the seven indicated compounds at a final concentration of 5 μM. After 24 h of incubation, growth was quantified as OD600, and fluconazole MICs determined as the lowest concentration resulting in a 50% decrease in growth. The fluconazole MIC occurring with each drug treatment was then expressed relative to the fluconazole-alone control (DMSO).